Did you know? · Science & Medicine

In his eighties, Perutz took on Huntington's disease

In his final years Max Perutz studied Huntington's disease, showing that its age of onset is linked to the number of glutamine repeats, which form a 'polar zipper'.

Max Perutz
Max Perutz · 1914–2002
Person
Max Perutz
Lived
1914–2002
Field
Molecular biology
From
Austrian-British

The story

Most scientists slow down in their eighties. Max Perutz retired as chairman of the Laboratory of Molecular Biology in Cambridge in 1979, but he kept working in the laboratory almost every day and published more than 100 papers and articles in his retirement. Asked once why he had not retired at 65, he said he had been tied up in some very interesting research at the time. In his final years he took on a new and urgent problem: the protein changes behind Huntington's disease and other neurodegenerative disorders.

Huntington's disease is caused by a gene in which a short DNA sequence, the triplet CAG, is repeated too many times. Each repeat adds one unit of the amino acid glutamine to the protein the gene makes, producing an abnormally long polyglutamine stretch. Several inherited brain disorders, including some spinocerebellar ataxias, arise in the same way, and in general the longer the stretch, the earlier in life the disease tends to appear.

Perutz brought a structural biologist's eye to the problem. He developed a strong interest in the structure of these polyglutamine tracts and proposed that glutamine stretches can bind together into what he called a polar zipper, linking protein chains and causing them to clump. He demonstrated that the age at which Huntington's disease begins is related to the number of glutamine repeats, connecting the molecular structure to the course of the illness.

He kept working until the very end. He was active in the laboratory almost every day until the Friday before Christmas in 2001 and submitted his last paper just a few days before that. He died of cancer in Cambridge on 6 February 2002, at the age of 87.

His late work helped focus attention on protein aggregation. Proteins with long polyglutamine stretches are now known to be increasingly prone to forming clumps that build up into fibrous deposits, sharing features with the amyloid found in other brain diseases. Understanding why these proteins stick together is a key question for scientists studying Huntington's disease.

Why it matters

Perutz's insight into protein clumping contributed to a major line of research into devastating brain diseases.

About Max Perutz

Viennese refugee who spent 22 years solving the structure of haemoglobin, won the 1962 Nobel Prize and built the Cambridge laboratory where molecular biology came of age.

Read the full profile
Max Perutz
1914–2002 · Molecular biology
View profile →

More about Max Perutz

Sources

Another act of tikkun olam. This is part of tikkun olam, the Jewish idea of repairing the world, and every one of us can add to it.

More in Science & Medicine

On kindness & the treatment of others
“A friend is devoted at all times; a brother is born to share adversity.”
Proverbs 17:17